CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties
2023 · Signal Transduction and Targeted Therapy · 65 citations
https://doi.org/10.1038/s41392-023-01555-9
R
Rui Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
153
Papers
3.5K
Citations
29
h-index
68
i10-index
Rui Liu is an academic researcher from Anhui Medical University. The author has contributed to research in topics: Fibroblast Growth Factor Research & Epigenetics and DNA Methylation & Cancer, Hypoxia, and Metabolism. The author has an h-index of 29, co-authored 131 publications.
ORCID: 0000-0001-8757-3159Papers by this author
worksOxygen-sensitive methylation of ULK1 is required for hypoxia-induced autophagy
2022 · Nature Communications · 61 citations
https://doi.org/10.1038/s41467-022-28831-6
AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth
2023 · Journal of Experimental & Clinical Cancer Research · 61 citations
https://doi.org/10.1186/s13046-023-02927-3
Mutual regulation between phosphofructokinase 1 platelet isoform and VEGF promotes glioblastoma tumor growth
2022 · Cell Death and Disease · 53 citations
https://doi.org/10.1038/s41419-022-05449-6
A review of S100 protein family in lung cancer
2017 · Clinica Chimica Acta · 50 citations
https://doi.org/10.1016/j.cca.2017.11.010
The natural compound GL22, isolated from Ganoderma mushrooms, suppresses tumor growth by altering lipid metabolism and triggering cell death
2018 · Cell Death and Disease · 47 citations
https://doi.org/10.1038/s41419-018-0731-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat